Traws Pharma
TRAW
28 hedge funds and large institutions have $1.01M invested in Traws Pharma in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 28 → 28 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.04% less ownership
Funds ownership: 0.33% → 0.3% (-0.04%)
34% less capital invested
Capital invested by funds: $1.54M → $1.01M (-$527K)
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$23.9K |
| 2 |
Jane Street
New York
|
+$11.4K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$264 |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$151 |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$75 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
-$57.3K |
| 2 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$30K |
| 3 |
Renaissance Technologies
New York
|
-$28.3K |
| 4 |
Millennium Management
New York
|
-$21.7K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$18.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CPG
26
Cornerstone Planning Group
Fairfield,
New Jersey
| $29 | +$19 | +1 | New |
|
|
SFI
27
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
| – | -$30K | -1,356 | Closed |
|
|
EL
28
EMFO LLC
Weston,
Florida
| – | -$3K | -133 | Closed |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$38 | -2 | -50% |
|
TRAW Hedge Fund Activity: Q4 2022 in Review
28 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Traws Pharma (TRAW) for Q4 2022, worth a combined $1.01M — down 34% from $1.54M a quarter earlier.
Fund positioning in TRAW was balanced in Q4 2022: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 10 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $23.9K. The largest seller was Two Sigma Advisers, cutting an estimated $57.3K.
- 28 institutional investors held Traws Pharma (TRAW) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $1.01M of Traws Pharma stock for Q4 2022, down 34% quarter-over-quarter.
- 3 funds opened new Traws Pharma positions in Q4 2022 and 3 closed out, a net change of 0 holders.
- The largest Traws Pharma buyer in Q4 2022 was Two Sigma Securities, an estimated $23.9K added.
- The largest Traws Pharma seller in Q4 2022 was Two Sigma Advisers, an estimated $57.3K sold.
Based on aggregated 13F filings for Q4 2022.